L-citrulline malate (DrugBank: Citrulline, L-Citrulline)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
86 | 肺動脈性肺高血圧症 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01683981 (ClinicalTrials.gov) | August 2012 | 1/9/2012 | Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate | Exercise Capacity and Quality of Life in Patients With Idiopathic Pulmonary Hypertension and Eisenmenger Syndrome Receiving Short Term Oral L-Citrulline Malate | Idiopathic Pulmonary Arterial Hypertension;Eisenmenger Syndrome | Drug: L-Citrulline Malate | Masih Daneshvari Hospital | NULL | Recruiting | 15 Years | 70 Years | Both | 25 | Phase 0 | Iran, Islamic Republic of |